The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

South Africa's new maternity care guidelines address a critical gap by recognising maternal mental health, yet implementation ...

Encephalitis survivors experience hidden mental health struggles and there is an urgent need for improved support within the ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

An experimental treatment for depression that triggers seizures with magnets significantly improved mental health in patients ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

The city’s police department has put a focus on officer mental health and well-being. That’s a big cultural change because ...